![Lilly to focus on new drugs in China, unload antibiotics brands and manufacturing facility for $375M | FiercePharma Lilly to focus on new drugs in China, unload antibiotics brands and manufacturing facility for $375M | FiercePharma](https://qtxasset.com/fiercepharma/1556026724/LillyChina.jpg?VersionId=jkLsae7xihc8_ZdUU14DFmSmzg8HMCA6)
Lilly to focus on new drugs in China, unload antibiotics brands and manufacturing facility for $375M | FiercePharma
![Eli Lilly to halt sales of 340B drugs to contract pharmacies with exception of insulin | Fierce Healthcare Eli Lilly to halt sales of 340B drugs to contract pharmacies with exception of insulin | Fierce Healthcare](https://qtxasset.com/quartz/qcloud5/media/image/fiercehealthcare/1599068351/elilillysign.png/elilillysign.png?VersionId=9Ae.8Jwl9TpRlw9bCjxb9RhyjM4WKKQi)
Eli Lilly to halt sales of 340B drugs to contract pharmacies with exception of insulin | Fierce Healthcare
![An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Picture taken March 5, 2021. REUTERS/Mike Segar Stock Photo - Alamy An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Picture taken March 5, 2021. REUTERS/Mike Segar Stock Photo - Alamy](https://c8.alamy.com/comp/2F1R1EG/an-eli-lilly-and-company-pharmaceutical-manufacturing-plant-is-pictured-at-50-imclone-drive-in-branchburg-new-jersey-march-5-2021-picture-taken-march-5-2021-reutersmike-segar-2F1R1EG.jpg)
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Picture taken March 5, 2021. REUTERS/Mike Segar Stock Photo - Alamy
![Eli Lilly faces FDA crackdown for manufacturing issues at plant handling COVID-19 antibody | FiercePharma Eli Lilly faces FDA crackdown for manufacturing issues at plant handling COVID-19 antibody | FiercePharma](https://qtxasset.com/fiercepharma/1602680764/Lilly.jpg/Lilly.jpg?VersionId=vc2fpZ.2NZXiSncxJ3YrnOtpr3Dll8UF)
Eli Lilly faces FDA crackdown for manufacturing issues at plant handling COVID-19 antibody | FiercePharma
![FDA authorizes Eli Lilly antibody drug that Trump touted, but supply will be limited - The Washington Post FDA authorizes Eli Lilly antibody drug that Trump touted, but supply will be limited - The Washington Post](https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/NPAY4LAZCII6XC62QFGKK3QTRM.jpg)